This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

ST Pharm


Founded in 1983, ST Pharm has been offering excellent custom manufacturing services of oligonucleotide and small molecule APIs to meet clients’ high expectation for their use in pharmaceutical development in compliance to cGMP requirements. Our reliability in service, which is well-proven through decades of business relationship with many big pharmas and biotech clients, is the essence of our strength along with our expertise in process development and scale-up optimization. Historically, ST Pharm has been focusing our expertise on nucleoside based pharmaceuticals; before leveraging into oligonucleotide API manufacture, we used to be the world largest supplier of Thymidine in the late 1990s, Zidovudine DS in the mid-2000s and deoxy-PNSs in the early 2000s other than phosphoramidites. ST Pharm is continuously expanding the oligonucleotide manufacture capacity with multiple large scale production lines and resources for process and analytic support.


We're bringing you

  • ST Pharm: Expansion of Oligonucleotide Manufacture Capacity

    On Demand
  • ST Pharm: Expansion of Oligonucleotide Manufacture Capacity